ABSTRACT
INTRODUCTION
Long noncoding RNAs (lncRNAs) have emerging roles in innate and adaptive immunity. For example, lnc-DC is required for normal dendritic cell differentiation and function 1 , IL1β-eRNA and IL1β-RBT46 are required for LPS-induced proinflammatory responses in monocytes 2 , and NRAV modulates cellular responses to viral infections 3 . In T cells, an intronic lncRNA NRON abrogates the nuclear transport of NFAT, and hence modulates expression of IL-2 4 . In B cell lymphomas, the lncRNA
Fas-AS1 modulates expression of soluble Fas receptor mRNA, an important regulator of apoptosis 5 . Thus lncRNAs have the potential to influence both normal and pathological immune cell development and function.
LncRNAs may operate via a variety of molecular mechanisms 6 . For example, enhancer-associated lncRNAs (eRNAs) act in cis and originate from transcribed extragenic or intragenic enhancer regions, whereas promoter-associated lncRNAs (pRNAs) can act in trans and originate from canonical promoter-derived transcriptional activity 7, 8 . These two broad lncRNA categories are distinguished by the ratio of mono-versus tri-methylation of histone 3 lysine 4 (H3K4me1/3) 8 .
Compared with pRNAs, eRNAs tend to exhibit more restricted expression and their RNA sequences show less constraint 8 .
Advances in sequencing technology have enabled the identification of large numbers of putative lncRNA loci 9, 10 . However, the proportion of lncRNAs with clearly defined function is small 11, 12 , caused in part by poor annotation of lncRNAs expressed in a tissue of interest, making it difficult to select candidate lncRNAs for targeted studies.
This is a consequence of the expression patterns of lncRNAs which are often restricted to one, or very few tissues or cell types 9 . Recent studies have addressed this limitation by surveying lncRNA expression in a number of organisms and tissues [13] [14] [15] [16] [17] , including murine T cells 18 . However, there have been no comparable attempts to use sequencing technologies to describe the murine B cell lncRNA repertoire.
To facilitate the study of lncRNA biology in B cells, we describe here a catalogue of 4516 de novo assembled high-confidence lncRNAs expressed in 11 mouse B cell populations. We identify human lncRNAs that may be orthologues of the mouse genes. Furthermore, we classify subsets of eRNAs and pRNAs, and perform an unsupervised clustering analysis to associate lncRNAs with mRNAs at key stages of B cell development. Finally, we utilize the lncRNA catalogue to show that PAX5, a transcription factor required to specify the B cell lineage 19 , binds to and regulates expression of lncRNA loci in both pro-B and mature B cells, as well as in acute lymphoblastic leukemia.
MATERIALS AND METHODS

Mice
All RNA-seq and ChIP-seq experiments were performed with female C57BL/6JNimr mice aged 7-9 weeks, except for RNAseq of plasmablasts and plasma cells which were obtained from 12-14 week old Blimp1-GFP mice 20 .
Cell Sorting
Gating strategies for cell sorting are shown in Supplemental Figure 1 .
RNA-seq
Sorted populations of cells were re-suspended in Trizol (Life Technologies), and RNA was purified using the RNeasy Mini Kit (Qiagen). RNA quality was assessed using the 2100 Expert Agilent Bioanalyser. For all samples except plasmablasts and plasma cells, stranded polyA-enriched libraries were made using the Stranded TruSeq RNA Sample Preparation Kit (Illumina) and sequenced on the HiSeq 2500 (Illumina), collecting 100 base paired-end reads. For plasma cells and plasmablasts, unstranded non-rRNA-enriched libraries were made using the SMARTer Ultra Low
Input RNA Kit for Sequencing v3 (Clontech) and sequenced collecting 50 base paired-end reads. All RNA-seq and ChIP-seq data (see below) has been deposited at NCBI Gene Expression Omnibus (accession number GSE72019).
ChIP-seq
Chromatin immunoprecipitation-sequencing was performed in triplicate for all stages of B cell development, except plasmablasts and plasma cells, as described
. For details see Supplemental Methods.
RNA-seq read alignment and transcript assembly
RNA-seq reads were aligned to the C57BL/6J mouse reference genome (mm10, GRCm38) using STAR 22 v2.3.0e. Transcript assembly was performed separately for all samples except plasmablasts and plasma cells using Cufflinks 23 v2.2.0. Nonuniquely mapping reads were retained during assembly and potential transcripts (transfrags) were discarded when they contained fewer than five successfully mapped reads. Individual assemblies were subsequently compared and transfrags were discarded if they were not assembled in at least two samples.
Identification of long non-coding RNAs
The lncRNA discovery pipeline is depicted in Supplemental Figure 2A . Following assembly, transcripts <200bp in length were discarded. Remaining transcripts were filtered against existing databases (Ensembl v72 and NCBI RefSeq), and discarded if they intersected (>=1bp, on the same strand) intervals annotated as anything other than non-coding RNA. Transcripts were also discarded if they were found to intersect Figure 2B) , in which successfully classified loci were required to intersect a called chromatin peak and to show four-fold greater coverage of reads arising from their characteristic chromatin mark.
UCSC public hub
Genomic data has been visualized as a UCSC public hub, accessible at https://www.cgat.org/downloads/public/projects/proj010/UCSC_track_hub/hub.txt.
RESULTS
lncRNA loci expressed during B cell development
In order to identify and characterize lncRNAs expressed during B cell development and activation, we used fluorescence-activated cell sorting to obtain 5 replicate cell samples for each of 8 purified B cell populations derived from the bone marrow, spleen, and peritoneal cavity of adult female C57BL/6JNimr mice ( Figure extracted and sequenced the polyA+ RNA fraction in a strand-specific manner to an average depth of 42 million uniquely mapped reads, using a 2x100 base paired-end sequencing protocol.
To identify lncRNAs we used a de novo transcript assembly pipeline (Supplemental Figure 2A) . Stringency of selection of potential lncRNA loci was assured by discarding transcripts whose assembly was not replicated in at least 2 of the 40 sample libraries, by discarding loci represented in public databases of protein-coding annotations (ENSEMBL & RefSeq), and by discarding loci containing transcripts with predicted coding potential (Supplemental Figure 3A -C). Using this process we identified 4516 lncRNA loci that were expressed in at least one of the 8 B cell
populations, and comprised, on average, 1.8 transcripts per locus (Supplemental Table 1 ). To validate the assembly process, we used PCR to check for expression of predicted lncRNAs. Of 53 lncRNAs with expression values ranging between 0.9 and 667 FPKM, we were able to successfully validate 47 (89%), demonstrating that the assembly pipeline had generated reliable transcripts (Supplemental Figure 4) . Table 2 ). The single-exon and multi-exon lncRNAs showed similar coding potential, expression levels and mean exon sizes, supporting the view that they belong to the same gene class (Supplemental Figure 5A-D) .
Intergenic B cell lncRNAs show little overlap with existing lncRNA catalogues
We compared the 2349 intergenic lncRNA loci identified in this study with intergenic lncRNAs reported in mouse T cell subsets 18 , and with the latest Ensembl (v74) long A previous study had shown that many lncRNAs overlap with transposable elements (TEs) 28 . In agreement with this, we find that around 40% of the lncRNAs identified here overlap with TEs, and a comparison of these with the genomic content of TEs shows an enrichment of endogenous retroviruses and a relative depletion of LINE elements, similar to the previous report ( Figure 1F , Supplemental Table 3 ).
In summary, we have generated a novel, high-confidence catalogue of lncRNAs expressed across key stages of B cell development. To facilitate the use of this catalogue, we have visualized our genomic data as a UCSC public hub, which can be accessed at https://www.cgat.org/downloads/public/projects/proj010/UCSC_track_hub/hub.txt.
Chromatin signatures identify intergenic lncRNAs with enhancer-associated and promoter-associated expression
In order to identify intergenic lncRNAs within our catalogue that may be either eRNAs or pRNAs, we determined the genome-wide abundance of H3K4me1 and H3K4me3 chromatin marks known to distinguish these two lncRNA subtypes 8 ( Figure 2A ,B).
We quantified the relative abundance of these marks at the proposed TSS of 2349 intergenic lncRNAs across all 8 B cell populations, and identified eRNAs and pRNAs using stringent selection criteria (Supplemental Figure 2B ). 
LncRNAs are expressed at discrete stages during B cell development
Previous studies in the T cell lineage had shown that intergenic lncRNA expression is highly restricted even between closely related T cell subsets 17, 18 . If this were also the case for B cells, then B cell subsets should be distinguishable on the basis of lncRNA To extend this analysis further we examined expression of the lncRNAs in antibodysecreting cells. We performed RNA-seq on splenic plasmablasts and plasma cells and on bone marrow plasma cells (Supplemental Figure 1E ,F Supplemental Figure   7E ) and determined expression of lncRNAs and coding genes in these three additional subsets (Supplemental Table 2 ). Principal component analysis showed that the 3 subsets clustered closely together (Supplemental Figure 7F ,G) and lncRNAs were again more cell type-specific ( Figure 3D ,E).
1
Generating hypotheses for lncRNA functions through correlation with proteincoding gene expression
One genome-scale approach to generate hypotheses regarding lncRNA function is to exploit a 'guilt by association' approach by correlating expression of lncRNAs with coding genes of known biological function 9, 29 . We predicted the biological processes to which lncRNAs might contribute by clustering protein-coding loci expressed in at least one B cell type (median FPKM>1) into one of 17 clusters, based on correlation of expression across B cell development 30 (Supplemental Figure 9A ,B, Supplemental Table 2 ). We subsequently correlated individual lncRNAs with the representative gene expression profile (eigengene) for each protein-coding cluster ( Figure 4A ), and defined an association between a lncRNA and a cluster of protein-coding genes at a
Pearson correlation coefficient of |ρ| > 0.8 ( Figure 4B ). At this threshold, 987 (22%) lncRNAs associated with protein-coding gene clusters, suggesting that these lncRNAs contribute to the same biological processes as the protein-coding genes within the respective cluster. While some clusters were characteristic of individual cell stages ( Figure 4A ), Gene Ontology enrichment analysis 31 identified others that were associated with cellular processes (Supplemental Table 4 Table 5 ).
Human lncRNA orthologues
To extend the utility of this catalogue of mouse lncRNAs, we sought to identify potential orthologous human lncRNAs by comparing the mouse genes to lncRNAs previously identified in human B cells 17, [33] [34] [35] . Based on pairwise genomic alignments we identified 185 mouse lncRNAs that have a human syntenic orthologue (Supplemental Table 6 ). Taking advantage of the fact that eRNAs are a distinct class of lncRNA throughout B cell development (Supplemental Figure 6D ) we compared mouse eRNAs with human eRNAs reported in CD19+ B cells 34 . Pairing eRNAs adjacent to orthologous human and mouse coding genes identified a further 228 mouse eRNAs that have one or more human eRNA counterparts (Supplemental Table 6 ). Such conserved location indicates that the human/mouse pairs may be marking enhancers of orthologous coding genes.
PAX5 regulates lncRNA expression during normal and malignant B cell development
The transcription factor PAX5 is expressed throughout B cell development and is crucial for commitment to the B cell lineage as well as for maintaining B cell Table 7 ). Furthermore, most (184) of these lncRNAs Table 6 ), suggesting that this transcriptional regulation may be conserved in human B cells. In total we report 199 lncRNAs (including 73 eRNAs) that are bound by PAX5, show PAX5-dependent expression, and are neighboring a protein-coding gene that also shows PAX5-dependent expression (Supplemental Table 7 ).
DISCUSSION
To aid in the identification of lncRNAs active within the immune system, we present a comprehensive catalogue of 4516 lncRNAs, including 2349 intergenic loci, expressed across 11 murine B cell populations. Translating genome-scale lncRNA identification 1 5 into in vivo functional studies remains a major challenge that necessitates the use of model organisms. Previous work has identified lncRNAs expressed in a subset of these populations in humans 17, [33] [34] [35] . However, given the high tissue-specificity and rapid evolution of lncRNAs, a murine catalogue is therefore a prerequisite to successful lncRNA studies in the mouse. In addition, we defined patterns of expression, chromatin modification, and transcription factor binding that provide insight into the regulation and function of these transcripts, and we identified a subset of lncRNAs that have human orthologues and thus are of direct relevance to human research.
The majority (67%) of lncRNA loci present in our catalogue contained no evidence of splicing. While single-exon transcripts had to be replicated in two or more samples to be included in this catalogue, their loci were less likely to be in published datasets. Half of all lncRNAs detected in B cells (52%) were intergenic (>5kb from a proteincoding gene). The use of H3K4me1 and H3K4me3 chromatin marks to distinguish eRNAs from pRNAs has been previously demonstrated 8 , and we were able to corroborate many of the features of these transcripts. The consistent classification of these loci across B cell development strongly suggests that these markers identify two distinct and mutually exclusive classes of lncRNA.
Comparison with lncRNAs expressed in human B cells identified 185 mouse lncRNAs that had a human orthologue, and a further 228 mouse eRNAs that have human eRNA counterparts. This offers the possibility of using the power of mouse genetics to study the in vivo function of these human lncRNAs by genetic modification of the corresponding mouse genes.
The use of expression correlation as a means of associating lncRNA function with that of protein-coding genes has been successfully demonstrated in previous studies 17, 18 . By clustering protein-coding genes on the basis of co-expression, we were able to identify discrete groups whose patterns of expression transcend individual B cell populations and whose members are associated with, for example, cell cycle function. Post hoc association of lncRNAs with these clusters implicated a substantial proportion (22%) of the lncRNAs with these specific processes. In addition this analysis supported the hypothesis that eRNAs may function to regulate expression of adjacent protein-coding genes 7 .
Using external data we identified loci regulated by PAX5, a crucial mediator of B cell development, whose loss contributes critically to the development of B-ALL 38 . After incorporating our classification of lncRNAs based on chromatin state, we identified 73 eRNAs situated proximal to protein-coding genes that also show Pax5-dependent expression in B-ALL cells. The roles of such transcripts remain to be investigated; however, their discovery demonstrates the utility of our catalogue when used in conjunction with external datasets to probe the complexities of B cell development and disease.
In conclusion, RNA-seq followed by de novo transcript assembly, has the potential to identify thousands of novel long non-coding transcripts. While a growing number of these transcripts have been assigned to diverse cellular processes, as yet, the majority have no known function. Given the large numbers of these transcripts, a major challenge when seeking to identify and characterize lncRNA function lies in the prioritization of plausible candidates for in vivo functional studies. We anticipate that this catalogue will serve as a valuable resource for such future research, for example by allowing systematic genetic screens of high-confidence lncRNAs to identify those with key functions in B cell development and activation. 
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